Foliachinenoside G

Details

Top
Internal ID 25c5f2b8-c329-4f67-8f37-4c4232db91c9
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty acyl glycosides > Fatty acyl glycosides of mono- and disaccharides
IUPAC Name (5R)-5-[8-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctyl]oxolan-2-one
SMILES (Canonical) C1CC(=O)OC1CCCCCCCCOC2C(C(C(C(O2)CO)O)O)O
SMILES (Isomeric) C1CC(=O)O[C@@H]1CCCCCCCCO[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O
InChI InChI=1S/C18H32O8/c19-11-13-15(21)16(22)17(23)18(26-13)24-10-6-4-2-1-3-5-7-12-8-9-14(20)25-12/h12-13,15-19,21-23H,1-11H2/t12-,13-,15-,16+,17-,18-/m1/s1
InChI Key JIHQLTXNRUMMRM-IYTWNDGFSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C18H32O8
Molecular Weight 376.40 g/mol
Exact Mass 376.20971797 g/mol
Topological Polar Surface Area (TPSA) 126.00 Ų
XlogP 1.00
Atomic LogP (AlogP) 0.24
H-Bond Acceptor 8
H-Bond Donor 4
Rotatable Bonds 11

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of Foliachinenoside G

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.8865 88.65%
Caco-2 - 0.8369 83.69%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.7143 71.43%
Subcellular localzation Mitochondria 0.8773 87.73%
OATP2B1 inhibitior - 0.8548 85.48%
OATP1B1 inhibitior + 0.9069 90.69%
OATP1B3 inhibitior + 0.9557 95.57%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior - 0.8602 86.02%
P-glycoprotein inhibitior - 0.7983 79.83%
P-glycoprotein substrate - 0.9407 94.07%
CYP3A4 substrate + 0.5638 56.38%
CYP2C9 substrate - 1.0000 100.00%
CYP2D6 substrate - 0.8814 88.14%
CYP3A4 inhibition - 0.9733 97.33%
CYP2C9 inhibition - 0.9032 90.32%
CYP2C19 inhibition - 0.8743 87.43%
CYP2D6 inhibition - 0.9305 93.05%
CYP1A2 inhibition - 0.9120 91.20%
CYP2C8 inhibition - 0.7922 79.22%
CYP inhibitory promiscuity - 0.9449 94.49%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.7201 72.01%
Eye corrosion - 0.9834 98.34%
Eye irritation - 0.7349 73.49%
Skin irritation - 0.8683 86.83%
Skin corrosion - 0.9602 96.02%
Ames mutagenesis - 0.6970 69.70%
Human Ether-a-go-go-Related Gene inhibition + 0.6943 69.43%
Micronuclear - 0.9700 97.00%
Hepatotoxicity - 0.7500 75.00%
skin sensitisation - 0.9407 94.07%
Respiratory toxicity - 0.7889 78.89%
Reproductive toxicity - 0.6444 64.44%
Mitochondrial toxicity + 0.5625 56.25%
Nephrotoxicity - 0.6346 63.46%
Acute Oral Toxicity (c) IV 0.4790 47.90%
Estrogen receptor binding - 0.8045 80.45%
Androgen receptor binding - 0.6805 68.05%
Thyroid receptor binding - 0.6378 63.78%
Glucocorticoid receptor binding - 0.5997 59.97%
Aromatase binding - 0.6033 60.33%
PPAR gamma - 0.5835 58.35%
Honey bee toxicity - 0.8799 87.99%
Biodegradation + 0.6000 60.00%
Crustacea aquatic toxicity - 0.6562 65.62%
Fish aquatic toxicity - 0.7090 70.90%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.55% 91.11%
CHEMBL220 P22303 Acetylcholinesterase 91.61% 94.45%
CHEMBL3137262 O60341 LSD1/CoREST complex 91.32% 97.09%
CHEMBL3060 Q9Y345 Glycine transporter 2 88.70% 99.17%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 88.52% 96.09%
CHEMBL2581 P07339 Cathepsin D 84.66% 98.95%
CHEMBL5255 O00206 Toll-like receptor 4 84.18% 92.50%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.64% 100.00%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 81.55% 95.56%
CHEMBL1977 P11473 Vitamin D receptor 81.21% 99.43%
CHEMBL5608 Q16288 NT-3 growth factor receptor 81.15% 95.89%

Cross-Links

Top
PubChem 53493975
NPASS NPC145876
LOTUS LTS0085597
wikiData Q105129063